Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 15 October 1993:
Vol. 262. no. 5132, pp. 419 - 421
DOI: 10.1126/science.8211162
Prev | Table of Contents | Next

Articles

Science, Vol 262, Issue 5132, 419-421
Copyright © 1993 by American Association for the Advancement of Science

articles

Converting tissue plasminogen activator to a zymogen: a regulatory triad of Asp-His-Ser

EL Madison, A Kobe, MJ Gething, JF Sambrook, and EJ Goldsmith

Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas 75235.

Unlike most serine proteases of the chymotrypsin family, tissue-type plasminogen activator (tPA) is secreted from cells as an active, single-chain enzyme with a catalytic efficiency only slightly lower than that of the proteolytically cleaved form. A zymogenic mutant of tPA has been engineered that displays a reduction in catalytic efficiency by a factor of 141 in the single-chain form while retaining full activity in the cleaved form. The residues introduced in the mutant, serine 292 and histidine 305, are proposed to form a hydrogen-bonded network with aspartate 477, similar to the aspartate 194-histidine 40-serine 32 network found to stabilize the zymogen chymotrypsinogen.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombin.
H. K. Kroh, P. Panizzi, and P. E. Bock (2009)
PNAS 106, 7786-7791
   Abstract »    Full Text »    PDF »
A Novel Mode of Intervention with Serine Protease Activity: TARGETING ZYMOGEN ACTIVATION.
G. E. Blouse, K. A. Botkjaer, E. Deryugina, A. A. Byszuk, J. M. Jensen, K. K. Mortensen, J. P. Quigley, and P. A. Andreasen (2009)
J. Biol. Chem. 284, 4647-4657
   Abstract »    Full Text »    PDF »
Mutational Analysis of Stubble-stubbloid Gene Structure and Function in Drosophila Leg and Bristle Morphogenesis.
A. S. Hammonds and J. W. Fristrom (2006)
Genetics 172, 1577-1593
   Abstract »    Full Text »    PDF »
Diapause in the mosquito Culex pipiens evokes a metabolic switch from blood feeding to sugar gluttony.
R. M. Robich and D. L. Denlinger (2005)
PNAS 102, 15912-15917
   Abstract »    Full Text »    PDF »
Functional Analysis of the Transmembrane Domain and Activation Cleavage of Human Corin: DESIGN AND CHARACTERIZATION OF A SOLUBLE CORIN.
S. Knappe, F. Wu, M. R. Masikat, J. Morser, and Q. Wu (2003)
J. Biol. Chem. 278, 52363-52370
   Abstract »    Full Text »    PDF »
The Structure of Human Prokallikrein 6 Reveals a Novel Activation Mechanism for the Kallikrein Family.
F. X. Gomis-Ruth, A. Bayes, G. Sotiropoulou, G. Pampalakis, T. Tsetsenis, V. Villegas, F. X. Aviles, and M. Coll (2002)
J. Biol. Chem. 277, 27273-27281
   Abstract »    Full Text »    PDF »
A catalytic switch and the conversion of streptokinase to a fibrin-targeted plasminogen activator.
G. L. Reed, A. K. Houng, L. Liu, B. Parhami-Seren, L. H. Matsueda, S. Wang, and L. Hedstrom (1999)
PNAS 96, 8879-8883
   Abstract »    Full Text »    PDF »
Identification of a Flexible Loop Region (297-313) of Urokinase-type Plasminogen Activator, Which Helps Determine Its Catalytic Activity.
Z. Sun, Y. Jiang, Z. Ma, H. Wu, B.-F. Liu, Y. Xu, W. Tang, Y. Chen, C. Li, D. Zhu, et al. (1997)
J. Biol. Chem. 272, 23818-23823
   Abstract »    Full Text »    PDF »
Variants of Tissue-type Plasminogen Activator That Display Extraordinary Resistance to Inhibition by the Serpin Plasminogen Activator Inhibitor Type 1.
K. Tachias and E. L. Madison (1997)
J. Biol. Chem. 272, 14580-14585
   Abstract »    Full Text »    PDF »
Identification of a Hydrophobic Exosite on Tissue Type Plasminogen Activator That Modulates Specificity for Plasminogen.
S.-H. Ke, K. Tachias, D. Lamba, W. Bode, and E. L. Madison (1997)
J. Biol. Chem. 272, 1811-1816
   Abstract »    Full Text »    PDF »
Converting Tissue Type Plasminogen Activator into a Zymogen. IMPORTANT ROLE OF Lys156.
K. Tachias and E. L. Madison (1997)
J. Biol. Chem. 272, 28-31
   Abstract »    Full Text »    PDF »
Converting Tissue-type Plasminogen Activator into a Zymogen.
K. Tachias and E. L. Madison (1996)
J. Biol. Chem. 271, 28749-28752
   Abstract »    Full Text »    PDF »
Variants of Tissue-type Plasminogen Activator with Substantially Enhanced Response and Selectivity toward Fibrin Co-factors.
L. Strandberg and E. L. Madison (1995)
J. Biol. Chem. 270, 23444-23449
   Abstract »    Full Text »    PDF »
Interaction of Single-chain Urokinase and Plasminogen Activator Inhibitor Type 1.
N. Manchanda and B. S. Schwartz (1995)
J. Biol. Chem. 270, 20032-20035
   Abstract »    Full Text »    PDF »
Variants of Tissue-type Plasminogen Activator Which Display Substantially Enhanced Stimulation by Fibrin.
K. Tachias and E. L. Madison (1995)
J. Biol. Chem. 270, 18319-18322
   Abstract »    Full Text »    PDF »
Substrate Specificity of Tissue Type Plasminogen Activator.
E. L. Madison, G. S. Coombs, and D. R. Corey (1995)
J. Biol. Chem. 270, 7558-7562
   Abstract »    Full Text »    PDF »
Catalytic Domain Structures of MT-SP1/Matriptase, a Matrix-degrading Transmembrane Serine Proteinase.
R. Friedrich, P. Fuentes-Prior, E. Ong, G. Coombs, M. Hunter, R. Oehler, D. Pierson, R. Gonzalez, R. Huber, W. Bode, et al. (2002)
J. Biol. Chem. 277, 2160-2168
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)